XPro1595

Drug identity checked against registry records

Also recorded as DN-TNF; INB03/XPro™; XENP1595

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
An Open-Label Extension of XPro1595 in Patients With Alzheimer's DiseaseNCT05522387INMBPhase 2Terminated2024-06-05Actual
A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of InflammationNCT05318976INMBPhase 2Completed2025-05-12Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.